Predicting patient trajectories is a complex task due to several factors, including data non-stationarity, the vast number of ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
A recent study led by Chenyang Lu, the Fullgraf Professor in computer science & engineering in the McKelvey School of Engineering and director of the AI for Health Institute (AIHealth) at Washington ...
Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...
HealthDay on MSN12d
Injectable Drug Resolves Dangerous Food Allergies In One-Third Of KidsMore than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Of course, science around estrogen and menopause—a noteworthy time of estrogen loss—is largely lacking: Research suggests ...
Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a ...
AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...
SNF-at-home programs are gaining traction as a viable solution to address the shortage of nursing home and rehabilitation ...
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback